Teachey, David T.
Bishop, Michael R.
Maloney, David G.
Grupp, Stephan A.
Article History
First Online: 13 February 2018
Competing interests
: D.T.T. has served on an advisory board for Amgen and has received research funding from Novartis. M.R.B. is a consultant for Celgene, KITE, and Novartis. D.G.M. has received research funding from Juno Therapeutics and honoraria from Celgene and KITE. S.A.G. is a consultant for and receives research funding from Novartis.